A5101714430- Bariatric Surgery and Outcomes
- Diet and metabolism studies
- Body Contouring and Surgery
- Gastric Cancer Management and Outcomes
- Diabetes Treatment and Management
- Obesity and Health Practices
- Esophageal and GI Pathology
- Liver Disease Diagnosis and Treatment
- Cardiovascular Disease and Adiposity
- Minimally Invasive Surgical Techniques
- Adipokines, Inflammation, and Metabolic Diseases
- Nutrition and Health in Aging
- Enhanced Recovery After Surgery
- Esophageal Cancer Research and Treatment
- Gastroesophageal reflux and treatments
- Helicobacter pylori-related gastroenterology studies
- Regulation of Appetite and Obesity
- Metabolism, Diabetes, and Cancer
- Adipose Tissue and Metabolism
- Hernia repair and management
- Lipid metabolism and disorders
- Appendicitis Diagnosis and Management
- Pharmacology and Obesity Treatment
- Colorectal Cancer Surgical Treatments
- Nutritional Studies and Diet
Min Sheng General Hospital
2015-2024
China Medical University Hospital
2023-2024
China Medical University
2023-2024
Nanjing Medical University
2023-2024
Kaohsiung Veterans General Hospital
2023
E-Da Hospital
2020-2022
Taipei Hospital
2017-2019
National Taiwan University Hospital
1996-2018
National Taiwan University
2008-2018
Tao Yuan General Hospital
2016
BACKGROUND Despite growing evidence that bariatric/metabolic surgery powerfully improves type 2 diabetes (T2D), existing treatment algorithms do not include surgical options. AIM The 2nd Diabetes Surgery Summit (DSS-II), an international consensus conference, was convened in collaboration with leading organizations to develop global guidelines inform clinicians and policymakers about benefits limitations of metabolic for T2D. METHODS A multidisciplinary group 48 clinicians/scholars (75%...
<h3>Importance</h3>Controlling glycemia, blood pressure, and cholesterol is important for patients with diabetes. How best to achieve this goal unknown.<h3>Objective</h3>To compare Roux-en-Y gastric bypass lifestyle intensive medical management control of comorbid risk factors.<h3>Design, Setting, Participants</h3>A 12-month, 2-group unblinded randomized trial at 4 teaching hospitals in the United States Taiwan involving 120 participants who had a hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>)...
In Brief Objectives: This prospective, randomized trial compared the safety and effectiveness of laparoscopic Roux-en-Y gastric bypass (LRYGBP) mini-gastric (LMGBP) in treatment morbid obesity. Summary Background Data: LRYGBP has been gold standard for While LMGBP reported to be a simple effective treatment, data from are lacking. Methods: Eighty patients who met NIH criteria were recruited receive either (n = 40) or 40). The minimum postoperative follow-up was 2 years (mean, 31.3 months)....
<h3>Importance</h3> The Roux-en-Y gastric bypass is effective in achieving established diabetes treatment targets, but durability unknown. <h3>Objective</h3> To compare of added to intensive lifestyle and medical management control targets. <h3>Design, Setting, Participants</h3> Observational follow-up a randomized clinical trial at 4 sites the United States Taiwan, involving 120 participants who had hemoglobin A<sub>1c</sub>(HbA<sub>1c</sub>) level 8.0% or higher body mass index between...
Abstract Objective: Hypoadiponectin has been documented in subjects with obesity, diabetes mellitus, or coronary heart disease, suggesting a potential use of plasma adiponectin following the clinical progress metabolic syndrome (MS). In this study, we investigated levels relation to variables MS among overweight/obese Asian subjects. Research Methods and Procedures: The adiponectin, anthropometric biochemical measurements, oral glucose tolerance tests (OGTT), modified insulin suppression...
Genetic variants in the fat mass and obesity-associated (FTO) gene have been linked with obesity type 2 diabetes European populations. We aimed to test role of FTO genetic Chinese population.
To find clinically meaningful preoperative predictors of diabetes remission and conversely inadequate glycemic control after gastric bypass surgery. Predicting the improvement in those with type 2 bariatric surgery may help patient selection.Preoperative details 154 ethnic Chinese subjects were examined for their influence on outcomes at 1 year bypass. Remission was defined as HbA(1c) ≤6%. Analysis involved binary logistic regression to identify provide equations receiver operating...
OBJECTIVE We compared 3-year achievement of an American Diabetes Association composite treatment goal (HbA1c &lt;7.0%, LDL cholesterol &lt;100 mg/dL, and systolic blood pressure &lt;130 mmHg) after 2 years intensive lifestyle-medical management intervention, with without Roux-en-Y gastric bypass, one additional year usual care. RESEARCH DESIGN AND METHODS A total 120 adult participants, BMI 30.0–39.9 kg/m2 HbA1c ≥8.0%, were randomized 1:1 to two arms at three clinical sites in...
Abstract Metabolic and bariatric surgery (MBS) is widely considered the most effective option for treating obesity, a chronic, relapsing, progressive disease. Recently, American Society of Bariatric Surgery (ASMBS) International Federation Obesity Disorders (IFSO) issued new guidelines on indications MBS, which have superseded previous 1991 National Institutes Health guidelines. The aim this study to establish first set consensus selecting procedures in Class I II using an Expert Modified...